Doses of histamine-2-receptor antagonists should be reduced in patients with low glomerular filtration rate.
Matzke
Gary R
GR
Virginia Commonwealth University, Schools of Pharmacy and Medicine, 410 N 12th Street, Suite 454C, PO Box 980533, Richmond, VA 23298-0533, USA. gmatzke@vcu.edu
D004305:Dose-Response Relationship, Drug; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control; D010437:Peptic Ulcer / Q000188:drug therapy / Q000378:metabolism; D012307:Risk Factors
D006635:Histamine H2 Antagonists